Predictors of Missed Research Appointments in a Randomized Placebo-Controlled Trial

Document Type : RESEARCH PAPER


Massachusetts General Hospital


 The primary aim of this study was to determine predictors of missed research appointments in a prospective  andomized placebo injection-controlled trial with evaluations 1 to 3 and 5 to 8 months after enrollment.  
 This study represents a secondary use of data from 104 patients that were enrolled in a prospective randomized  ontrolled trial of dexamethasone versus lidocaine (placebo) injection for various diagnoses. Patients were enrolled between June 2003 and February 2008. Sixty-three patients (61%) had lateral epicondylosis, 17 patients (16%) had trapeziometacarpal arthrosis, and 24 patients (23%) had de Quervain syndrome. Each patient completed a set of questionnaires at time of enrollment. Bivariable and multivariable analyses were used to determine factors associated with missed research appointments.
 Fourteen patients (13%) did not return for the first follow-up and 33 patients (32%) did not return for the second follow-up. The best multivariable logistic regression model for missing the first research visit explained 35% of the variability and included younger age, belief that health can be controlled, and no college education. The best model for missing the second research visit explained 17% of the variability and included greater pain intensity, less personal responsibility for health, and diagnosis (trapeziometacarpal arthrosis and de Quervain syndrome).
 Younger patients with no college education, who believe their health can be controlled, are more likely to miss a research appointment when enrolled in a randomized placebo injection-controlled trial. 


  1. Bryant DM, Willits K, Hanson BP. Principles of designing a cohort study in orthopaedics. J Bone Joint Surg Am. 2009;91:10-4.

  2. Orr PR, Blackhurst DW, Hawkins BS. Patient and clinic factors predictive of missed visits and inactive status in a multicenter clinical trial. The Macular Photocoagulation Study Group. Control Clin Trials. 1992; 13:40-9.

  3. Smith JS, Watts HG. Methods for locating missing patients for the purpose of long-term clinical studies. J Bone Joint Surg Am. 1998; 80:431-8.

  4. Sprague S, Leece P, Bhandari M, Tornetta P 3rd, Schemitsch E, Swiontkowski MF, et al. Limiting loss to follow-up in a multicenter randomized trial in orthopedic surgery. Control Clin Trials. 2003; 24:719-25.

  5. Murray DW, Britton AR, Bulstrode CJ. Loss to follow-up matters. J Bone Joint Surg Br. 1997; 79:254-7.

  6. Wildner M. Lost to follow-up. J Bone Joint Surg Br. 1995;77:657.

  7. Schonfeld T, Anderson J. Dropout by design: advance planning for research participant noncompliance. Am J Bioeth. 2011; 11:18-20.

  8. Lindenhovius A, Henket M, Gilligan BP, Lozano-Calderon S, Jupiter JB, Ring D. Injection of dexamethasone versus placebo for lateral elbow pain: a prospective, double-blind, randomized clinical trial. J Hand Surg Am. 2008; 33:909-19.

  9. Makarawung DJ, Becker SJ, Bekkers S, Ring D. Disability and pain after cortisone versus placebo injection for trapeziometacarpal arthrosis and de Quervain syndrome. Hand (N Y). 2013; 8:375-81.

  10. Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996; 29:602-8.

  11. Wallston KA, Wallston BS, DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Educ Monogr. 1978; 6:160-70.

  12. Eysenck HJ, Eysenck SBG. Manual for the Eysenck Personality Questionnaire (EPQ-R Adult). San Diego: Educational Industrial Testing Service; 1994.

  13. Radloff LS. ‘The CES-D scale: A self report depression scale for research in the general population. Appl Psychol Meas. 1977; 1:385-401.

  14. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 1977; 106:203-14.

  15. Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and Validation. Psychol Assess. 1995; 7:524-32.

  16. Grindley EJ, Zizzi SJ, Nasypany AM. Use of protection motivation theory, affect, and barriers to understand and predict adherence to outpatient rehabilitation. Phys Ther. 2008; 88:1529-40.

  17. Klenerman L, Slade PD, Stanley IM, Pennie B, Reilly JP, Atchison LE, et al. The prediction of chronicity in patients with an acute attack of low back pain in a general practice setting. Spine. 1995; 20:478-84.

  18. Murnaghan ML, Buckley RE. Lost but not forgotten: patients lost to follow-up in a trauma database. Can J Surg. 2002; 45:191-5.

  19. Tejwani NC, Takemoto RC, Nayak G, Pahk B, Egol KA. Who is lost to followup?: a study of patients with distal radius fractures. Clin Orthop Relat Res. 2010; 468:599-604.

  20. Chung SM, Scholl HW Jr, Ralston EL, Pendergrass EP. The colonna capsular arthroplasty. A long-term follow-up study of fifty-six patients. J Bone Joint Surg Am. 1971; 53:1511-27.

  21. Kemmler G, Hummer M, Widschwendter C, Fleischhacker WW. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis. Arch Gen Psychiatry. 2005; 62:1305-12.

  22. Bell RL, Curb JD, Friedman LM, McIntyre KM, Payton-Ross C. Enhancement of visit adherence in the national beta-blocker heart attack trial. Control Clin Trials. 1985; 6:89-101.

Volume 2, Issue 3 - Serial Number 3
September 2014
Pages 192-198
  • Receive Date: 30 March 2014
  • Revise Date: 10 June 2014
  • Accept Date: 16 July 2014
  • First Publish Date: 01 September 2014